UBS Group
ATHN

UBS Group’s Athenahealth, Inc. ATHN Stock Holding History

UBS Group’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,000
Closed -$2.52M – 8223
2016
Q4 		$2.52M Buy
+24,000
New +$2.58M ﹤0.01% 2707
2016
Q1 		– Sell
-100
Closed -$16K – 8501
2015
Q4 		$16K Hold
100
– – ﹤0.01% 6972
2015
Q3 		$13K Hold
100
– – ﹤0.01% 7100
2015
Q2 		$11K Hold
100
– – ﹤0.01% 7415
2015
Q1 		$12K Sell
100
-5,100
-98% -$680K ﹤0.01% 7518
2014
Q4 		$758K Buy
+5,200
New +$653K ﹤0.01% 3806

UBS Group's ATHN Position: Q1 2019 in Review

UBS Group sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 1,361,834 shares — an estimated $180M sold.

UBS Group first reported a position in ATHN in Q4 2014 and held it in 17 quarters. The position peaked at $180M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • UBS Group reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • UBS Group sold 1,361,834 Athenahealth, Inc. shares in Q1 2019, an estimated $180M.
  • UBS Group first reported a position in Athenahealth, Inc. in Q4 2014 and held it in 17 quarters.
  • UBS Group's Athenahealth, Inc. position peaked at $180M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.